(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 5.62%-11.09M | -99.05%-17.62M | 2.2M | 61.21%-11.75M | -8.85M | 81.46%-1.15M | -30.29M | 17.45%-6.2M | -72.87%4.87M | -255.32%-21.69M |
Net profit before non-cash adjustment | 96.07%37.47M | -61.76%8.43M | --2.7M | 109.01%19.11M | --22.04M | 34.80%-3.13M | ---212.15M | 54.80%-4.81M | -2,346.39%-11.82M | 57.38%-9.76M |
Total adjustment of non-cash items | -131.02%-12.54M | -159.98%-19.84M | --13K | -78.56%40.42M | --33.08M | -41.75%5.4M | --188.51M | -23.20%9.27M | 88.04%9.78M | -25.75%9.19M |
-Depreciation and amortization | -36.67%5.61M | -2,190.20%-619.89K | --2.41M | -75.27%8.85M | --29.66K | -27.87%5.84M | --35.79M | 2.31%8.09M | 57.85%7.28M | -13.03%6.87M |
-Reversal of impairment losses recognized in profit and loss | -162.15%-20.24M | -173.01%-20.24M | --0 | -77.07%32.56M | --27.72M | --1.6M | --141.96M | ---- | ---- | ---- |
-Share of associates | -183.10%-10.11M | -1,416.35%-2.51M | ---3.87M | -121.91%-3.57M | --190.94K | -1,008.11%-4.1M | --16.3M | -118.76%-370K | -98.72%44K | 87.27%1.1M |
-Disposal profit | 374.12%7.55M | 179.27%2.54M | --0 | 9.71%-2.75M | ---3.2M | --0 | ---3.05M | --0 | ---26K | --0 |
-Net exchange gains and losses | -35.40%306.05K | -98.27%86.05K | ---23K | 134.44%473.78K | --4.97M | 811.21%825K | ---1.38M | -112.17%-116K | 118.82%778K | -88.95%298K |
-Other non-cash items | -10.65%4.35M | -73.34%901.03K | --1.49M | 534.52%4.87M | --3.38M | -25.51%1.24M | ---1.12M | 34.46%1.67M | 31.86%1.7M | -22.85%915K |
Changes in working capital | 49.47%-36.02M | 90.30%-6.21M | ---512K | -972.16%-71.28M | ---63.98M | 67.97%-3.42M | ---6.65M | -19.17%-10.67M | -43.42%6.91M | -577.59%-21.12M |
-Change in receivables | -93.97%-30.74M | 34.67%-52.16M | --73.76M | 87.58%-15.85M | ---79.85M | 466.74%55.32M | ---127.65M | -161.46%-15.09M | 16.54%29.42M | -128.32%-17.88M |
-Change in inventory | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
-Change in payables | 90.49%-5.27M | 189.55%45.96M | ---74.28M | -145.81%-55.43M | --15.87M | -1,429.84%-58.74M | --121M | 112.99%4.42M | -69.29%-22.51M | 94.48%-3.24M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -21.73%-2.72M | -27.70%1.12M | -1.61M | 26.89%-2.23M | 1.54M | 24.84%-1.26M | -3.05M | -30.46%-1.68M | -32.63%-1.71M | 27.12%-938K |
Interest received (cash flow from operating activities) | ||||||||||
Tax refund paid | -51.98%-720.22K | 0 | 46.53%-473.9K | -126.53%-39K | -886.26K | -83.74%147K | 506K | -675.49%-791K | ||
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | -0.49%-14.52M | -121.36%-17.22M | --598K | 57.77%-14.45M | ---7.78M | 68.31%-2.45M | ---34.23M | 2.05%-7.74M | -77.98%3.66M | -212.53%-23.42M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -50.81%8.07M | --864.53K | ---- | 324.67%16.4M | ---- | --0 | --3.86M | --0 | 302.90%278K | ---252K |
Net investment product transactions | -80.20%2.52M | ---- | ---- | 143.04%12.74M | ---- | ---- | --5.24M | ---- | ---- | ---- |
Advance cash and loans provided to other parties | --0 | ---- | ---- | --0 | ---- | ---- | --0 | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | --3.76M | ---- | ---- | ---- |
Dividends received (cash flow from investment activities) | -31.00%3.45M | --0 | ---- | -23.08%5M | --1M | ---- | --6.5M | ---- | ---- | ---- |
Interest received (cash flow from investment activities) | 14.28%564.67K | 105.54%179.67K | --116K | 92.04%494.1K | ---3.24M | 61.54%21K | --257.3K | -72.92%13K | --10K | -77.23%23K |
Investing cash flow | -57.83%14.6M | -86.74%3.57M | --116K | 76.48%34.63M | --26.89M | 61.54%21K | --19.62M | -72.92%13K | 317.39%288K | -326.73%-229K |
Financing cash flow | ||||||||||
Net issuance payments of debt | -81.16%-3.44M | 1,238.22%20.3M | --828K | -445.50%-1.9M | ---1.78M | 51.06%-23K | --550.09K | 94.14%-47K | 105.16%1.18M | 95.18%-1.3M |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | --9.69M | --0 | --0 | -44.31%5.01M |
Increase or decrease of lease financing | 84.59%-25.15K | ---- | --1K | 68.91%-163.2K | ---- | 49.15%-30K | ---524.99K | -112.69%-59K | 84.52%-85K | -65.79%-63K |
Net other fund-raising expenses | -108.38%-516.48K | 51.02%9.96M | ---17.13M | 20,552.21%6.17M | --6.59M | 34.52%-1.23M | --29.86K | -187,800.00%-1.88M | ---- | ---- |
Financing cash flow | -197.14%-3.98M | 550.51%30.24M | ---16.3M | -57.89%4.1M | --4.65M | 35.35%-1.28M | --9.74M | -142.54%-1.98M | 106.91%959K | -48.89%3.65M |
Net cash flow | ||||||||||
Beginning cash position | 112.31%43.6M | 9.79%23.12M | --43.6M | -19.15%20.54M | --21.06M | 98.98%20.54M | --25.4M | -58.08%10.32M | -69.68%6.61M | 20.77%26.6M |
Current changes in cash | -116.09%-3.91M | -30.23%16.58M | ---15.59M | 599.04%24.28M | --23.76M | 61.75%-3.71M | ---4.87M | -204.42%-9.71M | 72.92%4.91M | -8,095.08%-20M |
Effect of exchange rate changes | 89.72%-124.79K | ---- | ---- | ---1.21M | ---- | ---- | ---- | ---- | ---- | ---- |
End cash Position | -9.24%39.57M | -9.24%39.57M | --28.01M | 112.31%43.6M | --43.6M | 2,631.33%16.83M | --20.54M | -97.13%616K | -58.08%10.32M | -69.68%6.61M |
Free cash flow | -1.96%-14.74M | -124.10%-17.44M | --598K | 60.56%-14.45M | ---7.78M | 68.31%-2.45M | ---36.64M | 2.05%-7.74M | -76.47%3.92M | -215.89%-23.67M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data